Product Information
KPT-6566 is a molecule that potently inhibits the interaction between tab29 and cancer stem cells. It has been shown to inhibit the growth of tumours by interfering with the regulation of reactive oxygen species (ROS) and mitochondrial function. KPT-6566 also interacts with cervical cancer cells, which leads to an increase in their death rate. The drug is also able to target cancer stem cells, which may be a treatment for cancers such as breast and prostate cancer. This drug has also been shown to interact with mirnas, which are important in gene transcription and proliferation.
Chemical properties
Technical inquiry about: 3D-GKB48777 KPT-6566
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.